Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COX-2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 496 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Turnbach, ME; Randich, A
      The effect of spinal and systemic administration of indomethacin on zymosan-induced edema, mechanical hyperalgesia, and thermal hyperalgesia

      JOURNAL OF PAIN
    2. Thompson, EJ; Gupta, A; Vielhauer, GA; Regan, JW; Bowden, GT
      The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1

      NEOPLASIA
    3. Williams, CS; Sheng, HM; Brockman, JA; Armandla, R; Shao, JY; Washington, MK; Elkahloun, AG; Dubois, RN
      A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established humancolon cancer xenografts

      NEOPLASIA
    4. Gallo, O; Franchi, A; Magnelli, L; Sardi, I; Vannacci, A; Boddi, V; Chiarugi, V; Masini, E
      Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

      NEOPLASIA
    5. McCarthy, DM
      Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    6. Hawkey, CJ
      COX-1 and COX-2 inhibitors

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    7. Giercksky, KE
      COX-2 inhibition and prevention of cancer

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    8. Penglis, PS; James, MJ; Cleland, LG
      Cyclooxygenase inhibitors: any reservations?

      INTERNAL MEDICINE JOURNAL
    9. Kistler, T; Ambuhl, PM
      Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion

      SWISS MEDICAL WEEKLY
    10. Allport, VC; Pieber, D; Slater, DM; Newton, R; White, JO; Bennett, PR
      Human labour is associated with nuclear factor-kappa B activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'

      MOLECULAR HUMAN REPRODUCTION
    11. Senior, K
      Tea: a rich brew of anti-cancer magic bullets?

      DRUG DISCOVERY TODAY
    12. Jackson, CG
      Therapeutic potential of COX-2 inhibitors in arthritis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS

    13. 2-(acetoxyphenyl)-(Z)-styryl sulfides as cyclooxygenase inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    14. Tokuyama, O; Nakamura, Y; Muso, A; Honda, KI; Ishiko, O; Ogita, S
      Expression and distribution of cyclooxygenase-2 in human periovulatory ovary

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    15. Sumi, T; Ishiko, O; Yoshida, H; Hyun, Y; Nakagawa, E; Hirai, K; Matsumoto, Y; Ogita, S
      Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    16. Matsumoto, Y; Ishiko, O; Deguchi, M; Nakagawa, E; Ogita, S
      Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    17. McCarthy, DM
      Helicobacter pylori and NSAIDs - What interaction

      EUROPEAN JOURNAL OF SURGERY
    18. Khan, KNM; Stanfield, KM; Dannenberg, A; Seshan, SV; Baergen, RN; Baron, DA; Soslow, RA
      Cyclooxygenase-2 expression in the developing human kidney

      PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
    19. DuBois, RN
      Cyclooxygenease-2 and hepatocellular carcinoma: Is it a target for prevention?

      CLINICAL CANCER RESEARCH
    20. Shirahama, T; Sakakura, C
      Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder

      CLINICAL CANCER RESEARCH
    21. Pyo, H; Choy, H; Amorino, GP; Kim, JS; Cao, QW; Hercules, SK; DuBois, RN
      A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2

      CLINICAL CANCER RESEARCH
    22. Bradley, JD
      Celecoxib and rofecoxib: A distinction with a difference?

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    23. McKenna, F; Weaver, A; Fiechtner, JJ; Bello, AE; Fort, JG
      COX-2 specific inhibitors in the management of osteoarthritis of the knee:A placebo-controlled, randomized, double-blind study

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    24. Kojima, M; Morisaki, T; Uchiyama, A; Doi, F; Mibu, R; Katano, M; Tanaka, M
      Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas

      ANNALS OF SURGICAL ONCOLOGY
    25. Harris, CJ; Brater, DC
      Renal effects of cyclooxygenase-2 selective inhibitors

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    26. Celotti, F; Laufer, S
      Anti-inflammatory drugs: New multitarget compounds to face an old problem.The dual inhibition concept

      PHARMACOLOGICAL RESEARCH
    27. Bloom, BJ
      New drug therapies for the pediatric rheumatic diseases

      CURRENT OPINION IN RHEUMATOLOGY
    28. James, MJ; Penglis, PS; Caughey, GE; Demasi, M; Cleland, LG
      Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?

      INFLAMMATION RESEARCH
    29. Suzuki, M; Hayashi, I; Nara, Y; Kumagai, Y; Okamoto, H; Hoka, S; Majima, M
      Participation of cyclooxygenases in cutaneous thermal nociception under non-inflamed and inflamed conditions

      INFLAMMATION RESEARCH
    30. Matsumoto, Y; Ishiko, O; Sumi, T; Yoshida, H; Deguchi, M; Nakagawa, E; Haba, T; Wakasa, K; Ogita, S; Ando, Y
      Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions

      ONCOLOGY REPORTS
    31. Deguchi, M; Ishiko, O; Sumi, T; Yoshida, H; Yamamoto, K; Ogita, S
      Expression of angiogenic factors in extrapelvic endometriosis

      ONCOLOGY REPORTS
    32. Ishiko, O; Sumi, T; Yoshida, H; Tokuyama, O; Wakasa, K; Haba, T; Ogita, S
      Cyclooxygenase-2 expression in an adenoid cystic carcinoma of the uterine cervix

      ONCOLOGY REPORTS
    33. Reichman, J; Cohen, S; Goldfarb, M; Shina, A; Rosen, S; Brezis, M; Karmeli, F; Heyman, SN
      Renal effects of nabumetone, a COX-2 antagonist: Impairment of function inisolated perfused rat kidneys contrasts with preserved renal function in vivo

      EXPERIMENTAL NEPHROLOGY
    34. Liu, SS; Yin, CS; Shi, YY; Cai, SX; Li, ZL
      MEDV-13 for QSAR studies on the COX-2 inhibition by indomethacin amides and esters

      CHINESE JOURNAL OF CHEMISTRY
    35. Ostensen, M; Villiger, PM
      Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus

      LUPUS
    36. Tang, CY; Shou, MG; Rushmore, TH; Mei, Q; Sandhu, P; Woolf, EJ; Rose, MJ; Gelmann, A; Greenberg, HE; De Lepeleire, I; Van Hecken, A; De Schepper, PJ; Ebel, DL; Schwartz, JI; Rodrigues, AD
      In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelicvariant forms of human liver microsomal cytochrome P4502C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics

      PHARMACOGENETICS
    37. Nakanishi, Y; Kamijo, R; Takizawa, K; Hatori, M; Nagumo, M
      Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

      EUROPEAN JOURNAL OF CANCER
    38. Thomas, T; Nadackal, TG; Thomas, K
      Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation

      NEUROREPORT
    39. Egan, CG; Lockhart, JC; McLean, JS; Ferrell, WR
      Expression of constitutive but not inducible cyclooxygenase maintains articular perfusion in the rat knee

      EXPERIMENTAL PHYSIOLOGY
    40. Hardwick, JCH; van den Brink, GR; Offerhaus, GJ; van Deventer, SJH; Peppelenbosch, MP
      NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps

      ONCOGENE
    41. Sepehr, A; Taniere, P; Martel-Planche, G; Zia'ee, AA; Rastgar-Jazii, F; Yazdanbod, M; Etemad-Moghadam, G; Kamangar, F; Saidi, F; Hainaut, P
      Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

      ONCOGENE
    42. King, JG; Khalili, K
      Inhibition of human brain tumor cell growth by the anti-inflammatory drug,flurbiprofen

      ONCOGENE
    43. Tang, QB; Chen, WX; Gonzales, MS; Finch, J; Inoue, H; Bowden, GT
      Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes

      ONCOGENE
    44. Chen, WX; Tang, QB; Gonzales, MS; Bowden, GT
      Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes

      ONCOGENE
    45. Peskar, BM
      Role of cyclooxygenase isoforms in gastric mucosal defence

      JOURNAL OF PHYSIOLOGY-PARIS
    46. Rainsford, KD
      The ever-emerging anti-inflammatories. Have there been any real advances?

      JOURNAL OF PHYSIOLOGY-PARIS
    47. Tanaka, A; Araki, H; Komoike, Y; Hase, S; Takeuchi, K
      Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs

      JOURNAL OF PHYSIOLOGY-PARIS
    48. Salam, OMEA; El-Shenawy, S; El-Batran, S; Arbid, MS; Mozsik, G
      The effect of etodolac on bile salt and histamine-mediated gastric mucosalinjury in the rat

      JOURNAL OF PHYSIOLOGY-PARIS
    49. Rarey, M; Stahl, M
      Similarity searching in large combinatorial chemistry spaces

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    50. Kamijo, T; Sato, T; Nagatomi, Y; Kitamura, T
      Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines

      INTERNATIONAL JOURNAL OF UROLOGY
    51. Sumitani, H; Kamijo, R; Toyoshima, T; Nakanishi, Y; Takizawa, K; Hatori, M; Nagumo, M
      Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E-2 production

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    52. Misra, UK; Pizzo, SV
      Induction of cyclooxygenase-2 synthesis by ligation of the macrophage alpha 2-macroglobulin signalling receptor

      CELLULAR SIGNALLING
    53. Hains, BC; Yucra, JA; Hulsebosch, CE
      Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398

      JOURNAL OF NEUROTRAUMA
    54. Kinoshita, Y; Ueyama, T; Senba, E; Terada, T; Nakai, K; Itakura, T
      Expression of c-fos, heat shock protein 70, neurotrophins, and cyclooxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their modification by magnesium sulfate

      JOURNAL OF NEUROTRAUMA
    55. Desiraju, GR; Sarma, JARP; Raveendra, D; Gopalakrishnan, B; Thilagavathi, R; Sobhia, ME; Subramanya, HS
      Computer-aided design of selective COX-2 inhibitors: comparative molecularfield analysis and docking studies of some 3,4-diaryloxazolone derivatives

      JOURNAL OF PHYSICAL ORGANIC CHEMISTRY
    56. Deng, WG; Ruan, KH; Du, M; Saunders, MA; Wu, KK
      Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts

      FASEB JOURNAL
    57. Khan, KNM; Burke, A; Stanfield, KM; Harris, RK; Baron, DA
      Expression of cyclooxygenase-2 in the macula densa of human kidney in hypertension, congestive heart failure, and diabetic nephropathy

      RENAL FAILURE
    58. Tabatabaie, T; Vasquez, AM; Moore, DR; Floyd, RA; Kotake, Y
      Direct administration of interleukin-1 and interferon-gamma to rat pancreas leads to the in vivo production of nitric oxide and expression of inducible nitric oxide synthase and inducible cyclooxygenase

      PANCREAS
    59. Sylvia, VL; Del Toro, F; Dean, DD; Hardin, RR; Schwartz, Z; Boyan, BD
      Effects of 1 alpha,25-(OH)(2)D-3 on rat growth zone chondrocytes are mediated via cyclooxygenase-l and phospholipase A(2)

      JOURNAL OF CELLULAR BIOCHEMISTRY
    60. Kotzan, J; Wade, W; Yu, HH
      Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population

      PHARMACEUTICAL RESEARCH
    61. Truitt, KE; Sperling, RS; Ettinger, WH; Greenwald, M; DeTora, L; Zeng, Q; Bolognese, J; Ehrich, E
      A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients withosteoarthritis

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    62. Hochberg, MC
      What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    63. Hawkey, CJ
      NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials?The gastroenterologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    64. Appel, GB
      COX-2 inhibitors and the kidney

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    65. Rodriguez, LAG
      The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    66. Patrono, C
      Measurement of cyclooxygenase isozyme inhibition in humans: exploring the clinical relevance of biochemical selectivity

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    67. Dionne, RA; Khan, AA; Gordon, SM
      Analgesia and COX-2 inhibition

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    68. Di Battista, JA; Fahmi, H; He, Y; Zhang, M; Martel-Pelletier, J; Pelletier, JP
      Differential regulation of interleukin-1 beta-induced cyclooxygenase-2 gene expression by nimesulide in human synovial fibroblasts

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    69. Tavares, IA; Borrelli, F; Welsh, NJ
      Inhibition of gastric acid secretion by nimesulide: A possible factor in its gastric tolerability

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    70. Kulkarni, SK; Jain, NK; Singh, A
      Nitric oxide-releasing NSAIDs: a new dimension in nonsteroidal antiinflammatory drugs

      DRUGS OF THE FUTURE
    71. Sorbera, LA; Castaner, RM; Silvestre, J; Castaner, J
      Etoricoxib - Analgesic drug, antiarthritic, cyclooxygenase-2 inhibitor

      DRUGS OF THE FUTURE
    72. Sorbera, LA; Leeson, PA; Castaner, J; Castaner, RM
      Valdecoxib and parecoxib sodium - Analgesic - Antiarthritic - Cyclooxygenase-2 inhibitor

      DRUGS OF THE FUTURE
    73. Elder, CL; Dahners, LE; Weinhold, PS
      A cyclooxygenase-2 inhibitor impairs ligament healing in the rat

      AMERICAN JOURNAL OF SPORTS MEDICINE
    74. Turull, A; Piera, C; Queralt, J
      Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats

      INFLAMMATION
    75. Mason, KA; Komaki, R; Cox, JD; Milas, L
      Biology-based combined-modality radiotherapy: Workshop report

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    76. Gaffney, DK; Holden, J; Davis, M; Zempolich, K; Murphy, KJ; Dodson, M
      Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    77. Nyska, A; Lomnitski, L; Maronpot, R; Moomaw, C; Brodsky, B; Sintov, A; Wormser, U
      Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced shin injury in guinea pigs

      ARCHIVES OF TOXICOLOGY
    78. Chen, JH; Liu, TY; Wu, CW; Chi, CW
      Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression

      MEDICAL HYPOTHESES
    79. Mathonnet, M; Lalloue, F; Danty, E; Comte, I; Ayer-Le Lievre, C
      Cyclo-oxygenase 2 tissue distribution and developmental pattern of expression in the chicken

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    80. Lee, TL; Leung, WK; Lau, JYW; Tong, JHM; Ng, EKW; Chan, FKL; Chung, SCS; Sung, JJY; To, KF
      Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer

      CANCER LETTERS
    81. Kagoura, M; Toyoda, M; Matsui, C; Morohashi, M
      Immunohistochemical expression of cyclooxygenase-2 in skin cancers

      JOURNAL OF CUTANEOUS PATHOLOGY
    82. Acevedo, E; Castaneda, O; Ugaz, M; Beaulieu, AD; Pons-Estel, B; Caeiro, F; Casas, N; Garza-Elizondo, M; Irazoque, F; Hinojosa, W; Gutierrez-Urena, S; Vandormael, K; Rodgers, DB; Laurenzi, M
      Tolerability profiles of rofecoxib (Vioxx (R)) and Arthrotoc (R) - A comparison of six weeks treatment in patients with osteoarthritis

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    83. Steinfeld, S; Poriau, S
      Patient and physician satisfaction with rofecoxib in osteoarthritis: Results of the EVA (experience with VIOXX in arthritis) survey

      CURRENT MEDICAL RESEARCH AND OPINION
    84. Dicker, AP; Williams, TL; Grant, DS
      Targeting angiogenic processes by combination rofecoxib and ionizing radiation

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    85. Gaffney, DK; Holden, J; Zempolich, K; Murphy, KJ; Dicker, AP; Dodson, M
      Elevated COX-2 expression in cervical carcinoma - Reduced cause-specific survival and pelvic control

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    86. Garnett, WR
      Clinical implications of drug interactions with coxibs

      PHARMACOTHERAPY
    87. Komers, R; Anderson, S; Epstein, M
      Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors

      AMERICAN JOURNAL OF KIDNEY DISEASES
    88. Barton, CC; Barton, EX; Ganey, PE; Kunkel, SL; Roth, RA
      Bacterial lipopolysaccharide enhances aflatoxin B-1 hepatotoxicity in ratsby a mechanism that depends on tumor necrosis factor alpha

      HEPATOLOGY
    89. Andreasson, KI; Savonenko, A; Vidensky, S; Goellner, JJ; Zhang, Y; Shaffer, A; Kaufmann, WE; Worley, PF; Isakson, P; Markowska, AL
      Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice

      JOURNAL OF NEUROSCIENCE
    90. Marino, G; Lewis, JH
      Drug-induced liver disease

      CURRENT OPINION IN GASTROENTEROLOGY
    91. Walker, MC; Kurumbail, RG; Kiefer, JR; Moreland, KT; Koboldt, CM; Isakson, PC; Seibert, K; Gierse, JK
      A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors

      BIOCHEMICAL JOURNAL
    92. Brater, DC; Harris, C; Redfern, JS; Gertz, BJ
      Renal effects of COX-2-selective inhibitors

      AMERICAN JOURNAL OF NEPHROLOGY
    93. Hachulla, E
      Specific inhibitors of Cox-2 and hemostasis the internists point of view

      REVUE DE MEDECINE INTERNE
    94. Olgen, S; Akaho, E; Nebioglu, D
      Synthesis and receptor docking studies of N-substituted indole-2-carboxylic acid esters as a search for COX-2 selective enzyme inhibitors

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    95. Caliendo, G; Santagada, V; Perissutti, E; Severino, B; Fiorino, F; Warner, TD; Wallace, JL; Ifa, DR; Antunes, E; Cirino, G; de Nucci, G
      Synthesis of substituted benzamides as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 but do not cause gastric damage

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    96. Dannhardt, G; Kiefer, W
      Cyclooxygenase inhibitors - current status and future prospects

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    97. Brands, MW; Hailman, AE; Fitzgerald, SM
      Long-term glucose infusion increases arterial pressure in dogs with cyclooxygenase-2 inhibition

      HYPERTENSION
    98. Salter, EA; Wierzbicki, A; Sperl, G; Thompson, WJ
      Molecular modeling study of COX-2 inhibition by diarylheterocycles and sulindac sulfide

      JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    99. Laudanno, OM; Cesolari, JA; Esnarriaga, J; Rista, L; Piombo, G; Maglione, C; Aramberry, L; Sambrano, J; Godoy, A; Rocaspana, A
      Gastrointestinal damage induced by celecoxib and rofecoxib in rats

      DIGESTIVE DISEASES AND SCIENCES
    100. Kandil, HM; Tanner, G; Smalley, W; Halter, S; Radhika, A; Dubois, RN
      Cyclooxygenase-2 expression in Barrett's esophagus

      DIGESTIVE DISEASES AND SCIENCES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 14:25:18